menu
    • menu
    [{"orgOrder":0,"company":"Lipogems","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"ITALY","productType":"Undisclosed","year":"2017","type":"Inapplicable","leadProduct":"Autologous Micro-Fragmented Adipose Tissue","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Phase IV","graph3":"Lipogems","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Injection","sponsorNew":"Lipogems \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Lipogems \/ Undisclosed"},{"orgOrder":0,"company":"Lipogems","sponsor":"Alira Health","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"ITALY","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Microfragmented Adipose Tissue","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Phase III","graph3":"Lipogems","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lipogems \/ Alira Health","highestDevelopmentStatusID":"10","companyTruncated":"Lipogems \/ Alira Health"}]

    Find Clinical Drug Pipeline Developments & Deals by Lipogems

    Menu

    Lipogems

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Lipogems

                            Italy arrow
                            Tides Europe
                            Not Confirmed

                            Lipogems

                            Italy arrow
                            Tides Europe
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Microfragmented Adipose Tissue

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase III

                            Sponsor : Alira Health

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis

                            Details : Microfragmented Adipose Tissue is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Osteoarthritis, Knee.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            December 21, 2022

                            Lead Product(s) : Microfragmented Adipose Tissue

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase III

                            Sponsor : Alira Health

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Lipogems

                            Italy arrow
                            Tides Europe
                            Not Confirmed

                            Lipogems

                            Italy arrow
                            Tides Europe
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Autologous Micro-Fragmented Adipose Tissue

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Single Intra-articular Injection of aMAT vs PRP in Patients With OA of the Knee

                            Details : Autologous Micro-Fragmented Adipose Tissue is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Osteoarthritis, Knee.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            April 18, 2017

                            Lead Product(s) : Autologous Micro-Fragmented Adipose Tissue

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth